Migdal Insurance & Financial Holdings Ltd. Has $318,000 Holdings in Synopsys, Inc. $SNPS

Migdal Insurance & Financial Holdings Ltd. lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 8.8% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 620 shares of the semiconductor company’s stock after purchasing an additional 50 shares during the quarter. Migdal Insurance & Financial Holdings Ltd.’s holdings in Synopsys were worth $318,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Cornerstone Planning Group LLC increased its position in shares of Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock worth $25,000 after buying an additional 44 shares during the period. Saudi Central Bank acquired a new stake in shares of Synopsys during the first quarter worth $26,000. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Synopsys by 441.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after buying an additional 53 shares during the period. Independence Bank of Kentucky increased its position in shares of Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares during the period. Finally, Princeton Global Asset Management LLC increased its position in shares of Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after buying an additional 53 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Synopsys Stock Down 0.3%

Synopsys stock opened at $455.34 on Thursday. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The firm has a market capitalization of $84.58 billion, a price-to-earnings ratio of 35.74, a price-to-earnings-growth ratio of 5.03 and a beta of 1.10. The firm’s fifty day moving average price is $500.33 and its two-hundred day moving average price is $514.51. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the business posted $3.43 earnings per share. The firm’s quarterly revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,655 shares of the firm’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the transaction, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at $9,339,847.09. This trade represents a 19.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. The trade was a 13.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on SNPS shares. Stifel Nicolaus decreased their price objective on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Mizuho reduced their price target on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Bank of America restated an “underperform” rating and issued a $525.00 price target (down from $625.00) on shares of Synopsys in a report on Wednesday, September 10th. Citigroup cut shares of Synopsys from a “neutral” rating to an “underperform” rating in a report on Wednesday, September 10th. Finally, Robert W. Baird restated a “neutral” rating and issued a $535.00 price target (down from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $569.67.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.